Oligomeric assembly of native-like precursors precedes amyloid formation by β-2 microglobulin

被引:104
作者
Eakin, CM [1 ]
Attenello, FJ [1 ]
Morgan, CJ [1 ]
Miranker, AD [1 ]
机构
[1] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA
关键词
D O I
10.1021/bi049792q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The deposition of beta-2-microglobulin (beta2m) as amyloid fibers results in debilitating complications for renal failure patients who are treated by hemodialysis. In vitro, wild-type beta2m can be converted to amyloid under physiological conditions by exposure to biomedically relevant concentrations of Cu2+. in this work, we have made comparative measurements of the structural and oligomeric changes in beta2m at time points preceding fibrillogenesis. Our results show Cu2+ mediates the formation of a monomeric, activated state followed by the formation of a discrete dimeric intermediate. The dimeric intermediates then assemble into tetra- and hexameric forms which display little additional oligomerization on the time scales of their own formation (< 1 h). Amyloid fiber formation progresses from these intermediate states but on much longer time scales (> 1 week). Although Cu2+ is necessary for the generation and stabilization of these intermediates, it is not required for the stability of mature amyloid fibers. This suggests that Cu2+ acts as an initiating factor of amyloidosis by inducing oligomer formation. H-1 NMR and near-UV circular dichroism are used to establish that oligomeric intermediates are native-like in structure. The native-like structure and discrete oligomeric size of beta2m amyloid intermediates suggest that this protein forms fibrils by structural domain swapping.
引用
收藏
页码:7808 / 7815
页数:8
相关论文
共 39 条
  • [1] Kinetic mechanism of end-to-end annealing of actin filaments
    Andrianantoandro, E
    Blanchoin, L
    Sept, D
    McCammon, JA
    Pollard, TD
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 312 (04) : 721 - 730
  • [2] Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy
    Aronoff-Spencer, E
    Burns, CS
    Avdievich, NI
    Gerfen, GJ
    Peisach, J
    Antholine, WE
    Ball, HL
    Cohen, FE
    Prusiner, SB
    Millhauser, GL
    [J]. BIOCHEMISTRY, 2000, 39 (45) : 13760 - 13771
  • [3] STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2
    BJORKMAN, PJ
    SAPER, MA
    SAMRAOUI, B
    BENNETT, WS
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1987, 329 (6139) : 506 - 512
  • [4] Copper and prion disease
    Brown, DR
    [J]. BRAIN RESEARCH BULLETIN, 2001, 55 (02) : 165 - 173
  • [5] The galvanization of β-amyloid in Alzheimer's disease
    Bush, AI
    Tanzi, RE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) : 7317 - 7319
  • [6] Pathologic conformations of prion proteins
    Cohen, FE
    Prusiner, SB
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 : 793 - +
  • [7] Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain
    Davis, DP
    Gallo, G
    Vogen, SM
    Dul, JL
    Sciarretta, KL
    Kumar, A
    Raffen, R
    Stevens, FJ
    Argon, Y
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 313 (05) : 1021 - 1034
  • [8] Formation of a copper specific binding site in non-native states of β-2-microglobulin
    Eakin, CM
    Knight, JD
    Morgan, CJ
    Gelfand, MA
    Miranker, AD
    [J]. BIOCHEMISTRY, 2002, 41 (34) : 10646 - 10656
  • [9] Removal of the N-terminal hexapeptide from human β2-microglobulin facilitates protein aggregation and fibril formation
    Esposito, G
    Michelutti, R
    Verdone, G
    Viglino, P
    Hernández, H
    Robinson, CV
    Amoresano, A
    Dal Piaz, F
    Monti, M
    Pucci, P
    Mangione, P
    Stoppini, M
    Merlini, G
    Ferri, G
    Bellotti, V
    [J]. PROTEIN SCIENCE, 2000, 9 (05) : 831 - 845
  • [10] Beta-2-microglobulin-associated amyloidosis - Discussion
    Floege, J
    Ehlerding, G
    [J]. NEPHRON, 1996, 72 (01) : 9 - 26